Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience. (3rd September 2021)

• Record Type: Journal Article
• Authors: Prinja, Shankar; Jyani, Gaurav; Gupta, Nidhi; Rajsekar, Kavitha
• Is Part Of: Expert review of pharmacoeconomics & outcomes research. Volume 21:Number 5(2021)
• Page Start: 859
• Page End: 868
• Publication Date: 2021-09-03
• Subjects: Health Technology Assessment -- economic evaluation -- cost-effectiveness analysis -- reference case -- methods -- India; Pharmacology -- Economic aspects -- Periodicals; 338.47615105
• DOI: 10.1080/14737167.2021.1921575
• Languages: English
• ISSNs: 1473-7167

Abstract

ABSTRACT: Introduction: Heterogeneity in methods of economic evaluation makes the use of health technology assessment (HTA) evidence difficult. Thereby, several countries including India have developed their own standard guidelines for conducting HTAs. However, diverse HTA studies involving drugs, medical devices, health programs, and platforms require an adaptation of the standard methods. Areas Covered: This review presents the specific characteristics of HTAs involving medical devices and health programs requiring adaptation of the standard guidelines. We use recent HTA studies in India to illustrate specific issues. These considerations involve the nature of decision-making problems, multiple scenarios in case of health programs, and specific attention to costing and the valuation of consequences. In case of medical devices, we discuss the issue of costing application of devices, multiple usage, learning curve for achieving effects, long causal path for health outcomes, and the issue of valuing false positives. Expert Opinion: While standard guidelines are essential, specific features of health programs and medical devices need to be considered while undertaking HTAs. Additionally, the context in which the HTA is being undertaken, characteristics of the health system, methods of financing healthcare, and demand-side characteristics of healthcare utilization should be reflected in the HTA for health programs and medical devices.